Sintilimab Recruiting Phase 3 Trials for Classic Hodgkin's Lymphoma Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Recruiting | Treatment | 3 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT04044222 | A Study to Evaluate the Efficacy and Safety of the Sintilimab Plus ICE Regimen Versus ICE Regimen in the Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed the First-line Standard Chemotherapy |